MXPA03010632A - Uso de inhibidores de nf-kb para tratar trastornos de resequedad de ojos. - Google Patents
Uso de inhibidores de nf-kb para tratar trastornos de resequedad de ojos.Info
- Publication number
- MXPA03010632A MXPA03010632A MXPA03010632A MXPA03010632A MXPA03010632A MX PA03010632 A MXPA03010632 A MX PA03010632A MX PA03010632 A MXPA03010632 A MX PA03010632A MX PA03010632 A MXPA03010632 A MX PA03010632A MX PA03010632 A MXPA03010632 A MX PA03010632A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- kappa
- dry eye
- eye disorders
- treat dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Los inhibidores de NF-KB son utiles para tratar trastornos de resequedad de ojos y otros trastornos que requieren la humectacion del ojo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29249501P | 2001-05-21 | 2001-05-21 | |
PCT/US2002/015859 WO2002095704A1 (en) | 2001-05-21 | 2002-05-17 | Use of nf-kappa-b inhibitors to treat dry eye disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03010632A true MXPA03010632A (es) | 2004-03-09 |
Family
ID=23124921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03010632A MXPA03010632A (es) | 2001-05-21 | 2002-05-17 | Uso de inhibidores de nf-kb para tratar trastornos de resequedad de ojos. |
Country Status (17)
Country | Link |
---|---|
US (1) | US6696453B2 (es) |
EP (1) | EP1393277B1 (es) |
JP (1) | JP2004527578A (es) |
CN (1) | CN1509462A (es) |
AT (1) | ATE333273T1 (es) |
AU (1) | AU2002309963B2 (es) |
BR (1) | BR0209965A (es) |
CA (1) | CA2447883A1 (es) |
CY (1) | CY1105220T1 (es) |
DE (1) | DE60213230T2 (es) |
DK (1) | DK1393277T3 (es) |
ES (1) | ES2263785T3 (es) |
MX (1) | MXPA03010632A (es) |
PL (1) | PL367286A1 (es) |
PT (1) | PT1393277E (es) |
WO (1) | WO2002095704A1 (es) |
ZA (1) | ZA200308769B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1542768A1 (en) * | 2002-09-20 | 2005-06-22 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
US6410516B1 (en) | 1986-01-09 | 2002-06-25 | President & Fellows Of Harvard College | Nuclear factors associated with transcriptional regulation |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US4996209A (en) | 1988-06-20 | 1991-02-26 | Alcon Laboratories, Inc. | Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
US5583150A (en) | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
EP0459148B1 (en) | 1990-05-29 | 1996-01-03 | Ocular Research Of Boston Inc. | Dry eye treatment composition |
ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
DE4028906A1 (de) | 1990-09-12 | 1992-03-19 | Paz Arzneimittelentwicklung | Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen |
DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
ZA927277B (en) | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
DE4140184C2 (de) | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Flurbiprofen enthaltendes Arzneimittel |
US5958912A (en) | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
DE69326836T2 (de) | 1992-04-21 | 2000-02-24 | The Schepens Eye Research Institute, Inc. | Androgentherapie am auge beim sjögrensyndrom |
US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
US5686436A (en) | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
US5561161A (en) | 1994-03-25 | 1996-10-01 | Oxigene, Inc. | Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof |
FR2718441B1 (fr) | 1994-04-07 | 1996-06-28 | Bioxytech | Nouveaux composés de structure benzisoséléna-zoline et -zine, leur procédé de préparation et leurs applications thérapeutiques. |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
US6335358B1 (en) | 1995-04-12 | 2002-01-01 | President And Fellows Of Harvard College | Lactacystin analogs |
JPH11511167A (ja) | 1995-08-14 | 1999-09-28 | オキシジェン インコーポレイティド | カロテノイド−ニコチンアミド−亜鉛組成物およびこれを使用した治療方法 |
US5696166A (en) | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
US6100299A (en) | 1996-03-08 | 2000-08-08 | Oxigene, Inc. | N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
US6028111A (en) | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
US6046185A (en) | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
US6071904A (en) | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
US6043083A (en) | 1997-04-28 | 2000-03-28 | Davis; Roger J. | Inhibitors of the JNK signal transduction pathway and methods of use |
US5916910A (en) | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
US6207458B1 (en) | 1998-05-07 | 2001-03-27 | University Of Washigton/Stowers Insitute For Medical Research | Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same |
DE69900207T2 (de) * | 1998-07-14 | 2001-11-22 | Alcon Laboratories, Inc. | Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation |
AU3074500A (en) | 1999-01-20 | 2000-08-07 | Kyowa Hakko Kogyo Co. Ltd. | Proteasome inhibitors |
US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
JP2002543058A (ja) | 1999-04-27 | 2002-12-17 | ノバルティス アクチエンゲゼルシャフト | プロテアソーム・インヒビターとしての2,4−ジアミノ−3−ヒドロキシカルボン酸誘導体の使用 |
-
2002
- 2002-05-17 PL PL02367286A patent/PL367286A1/xx not_active Application Discontinuation
- 2002-05-17 AU AU2002309963A patent/AU2002309963B2/en not_active Ceased
- 2002-05-17 BR BR0209965-9A patent/BR0209965A/pt not_active IP Right Cessation
- 2002-05-17 DE DE60213230T patent/DE60213230T2/de not_active Expired - Lifetime
- 2002-05-17 PT PT02736994T patent/PT1393277E/pt unknown
- 2002-05-17 CN CNA028102061A patent/CN1509462A/zh active Pending
- 2002-05-17 JP JP2002592087A patent/JP2004527578A/ja active Pending
- 2002-05-17 ES ES02736994T patent/ES2263785T3/es not_active Expired - Lifetime
- 2002-05-17 MX MXPA03010632A patent/MXPA03010632A/es active IP Right Grant
- 2002-05-17 CA CA002447883A patent/CA2447883A1/en not_active Abandoned
- 2002-05-17 EP EP02736994A patent/EP1393277B1/en not_active Expired - Lifetime
- 2002-05-17 US US10/150,219 patent/US6696453B2/en not_active Expired - Lifetime
- 2002-05-17 WO PCT/US2002/015859 patent/WO2002095704A1/en active IP Right Grant
- 2002-05-17 DK DK02736994T patent/DK1393277T3/da active
- 2002-05-17 AT AT02736994T patent/ATE333273T1/de active
-
2003
- 2003-11-11 ZA ZA2003/08769A patent/ZA200308769B/en unknown
-
2006
- 2006-09-14 CY CY20061101314T patent/CY1105220T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US6696453B2 (en) | 2004-02-24 |
CA2447883A1 (en) | 2002-11-28 |
EP1393277B1 (en) | 2006-07-19 |
CY1105220T1 (el) | 2010-03-03 |
ATE333273T1 (de) | 2006-08-15 |
ES2263785T3 (es) | 2006-12-16 |
US20030008854A1 (en) | 2003-01-09 |
DE60213230T2 (de) | 2006-11-23 |
CN1509462A (zh) | 2004-06-30 |
WO2002095704A1 (en) | 2002-11-28 |
BR0209965A (pt) | 2004-04-06 |
DE60213230D1 (de) | 2006-08-31 |
AU2002309963B2 (en) | 2007-03-01 |
EP1393277A1 (en) | 2004-03-03 |
ZA200308769B (en) | 2005-01-26 |
WO2002095704A9 (en) | 2003-02-27 |
DK1393277T3 (da) | 2006-10-30 |
WO2002095704A8 (en) | 2003-09-18 |
PL367286A1 (en) | 2005-02-21 |
JP2004527578A (ja) | 2004-09-09 |
PT1393277E (pt) | 2006-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002305756A8 (en) | Use of nf-kappa-b inhibitors to treat dry eye disorders | |
CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
PL350291A1 (en) | Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | |
WO2001015678A3 (en) | Topical use of kappa opioid agonists to treat otic pain | |
HK1066482A1 (en) | Use os fucans in the treatment of adhesions, arthritis and psoriasis | |
WO2003032916A3 (en) | Organosulfur inhibitors of tyrosine phosphatases | |
WO2002016429A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
AU3831301A (en) | Method for treating ocular pain | |
DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
WO2003099266A3 (en) | Acetamides and benzamides that are useful in treating sexual dysfunction | |
MXPA02004701A (es) | Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos. | |
WO2002016581A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2003039453A3 (en) | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use | |
MXPA03001643A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
MXPA03007653A (es) | Uso de lp82 para tratar trastornos hematopoyeticos. | |
WO2001015677A3 (en) | Use of 5-ht1b/1d agonists to treat otic pain | |
EP1546377A4 (en) | METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING MOLECULES 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 OR 13424 | |
MXPA03010632A (es) | Uso de inhibidores de nf-kb para tratar trastornos de resequedad de ojos. | |
AU2002347984A1 (en) | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders | |
EP1372648A4 (en) | KIEASE TIE2 RECEPTOR INHIBITORS FOR THE TREATMENT OF ANGIOGENIC DISEASES | |
MXPA03000313A (es) | Uso de fosfato de estramustina en el tratamiento de metastasis osea. | |
HK1059391A1 (en) | Use of quetiapine for the treatment of cocaine dependence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |